CenterWatch
Skip to content
Search Clinical Trials
Clinical Trial Listings
Volunteer
Learn About Clinical Trials
Sollefteã¥, Sweden
Search
Location
Distance
< 2 Miles
search
Actively Recruiting
Disclaimer
Clear Filters
Featured
A Phase 2, Open-Label, Randomized, Multicenter Study to Evaluate the Efficacy and Safety of Pemigatinib Plus Pembrolizumab Versus Pemigatinib Alone Versus Standard of Care as First-Line Treatment for Metastatic or Unresectable Urothelial Carcinoma in Cisplatin-Ineligible Participants Whose Tumors Express FGFR3 Mutation or Rearrangement
Phase
2
Span
Sponsor
Kita-Gun, Kita-Gun
Recruiting
READ MORE
Cohort Study of the Clinical Course of Macular Diseases in Kagawa
Phase
4
Span
527 weeks
Sponsor
Kagawa University
Miki, Kagawa
Recruiting
READ MORE
1-2 of 2
keyboard_double_arrow_left
arrow_right_alt
1
arrow_right_alt
keyboard_double_arrow_right